|
Basic Biology III: |
Sean Wu |
Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells |
$1,264,248 |
|
Tools and Technologies II: |
Brian Rutt |
Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters |
$1,833,348 |
|
Early Translational III: |
Bertha Chen |
Autologous iPSC Therapy for Urinary Incontinence |
$5,025,428 |
|
Tools and Technologies III: |
Joseph Wu |
Advanced animal model for predictive preclinical testing of engineered cardiac autografts and allografts |
$1,713,456 |
|
Tools and Technologies III: |
Anthony Oro |
A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability |
$1,403,822 |
|
Disease Team Research I: |
Gary Steinberg |
Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke |
$18,026,648 |
|
Tools and Technologies II: |
Irving Weissman |
Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs |
$1,463,881 |
|
Transplantation Immunology: |
Judith Shizuru |
Purified allogeneic hematopoietic stem cells as a platform for tolerance induction |
$1,233,275 |
|
Basic Biology IV: |
Alexander Dunn |
Role of mechanical signaling in stem cell self-renewal and differentiation |
$1,064,224 |
|
Basic Biology IV: |
Michelle Monje |
Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain |
$1,264,248 |
|
Basic Biology III: |
Joanna Wysocka |
Enhancer-mediated gene regulation during early human embryonic development |
$1,420,838 |
|
Disease Team Therapy Development - Research: |
Judith Shizuru |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$19,068,382 |
|
Tissue Collection for Disease Modeling: |
Joachim Hallmayer |
Induced pluripotent stem cells from children with autism spectrum disorders |
$530,265 |
|
Tools and Technologies III: |
Fan Yang |
Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival |
$0 |
|
Tools and Technologies III: |
Sarah Heilshorn |
Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System |
$0 |
|
Tools and Technologies III: |
Irving Weissman |
Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transplan |
$0 |
|
Basic Biology IV: |
Michael Cleary |
Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells |
$1,244,455 |
|
Creativity Awards: |
Paul Utz |
[REDACTED] Program: Stem Cell & Developmental Biology Research Internships |
$357,864 |
|
Basic Biology IV: |
Gerald Crabtree |
Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch |
$1,392,426 |
|
Disease Team Therapy Development - Research: |
Joseph Wu |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$19,942,877 |
|
New Cell Lines: |
Renee Reijo Pera |
Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype |
$1,409,243 |
|
Comprehensive Grant: |
Stefan Heller |
Generation of inner ear sensory cells from human ES cells toward a cure for deafness |
$2,330,371 |
|
SEED Grant: |
Susan McConnell |
Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease |
$607,363 |
|
Tissue Collection for Disease Modeling: |
Joseph Wu |
Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases |
$1,291,834 |
|
Basic Biology III: |
Aaron Hsueh |
Correlated time-lapse imaging and single cell molecular analysis of human embryo development |
$1,260,087 |
|
Early Translational IV: |
Michele Calos |
Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B |
$1,876,253 |
|
Tools and Technologies II: |
Sarah Heilshorn |
Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels |
$600,695 |
|
Early Translational III: |
Joseph Wu |
Heart Repair with Human Tissue Engineered Myocardium |
$4,397,241 |
|
Early Translational III: |
Helen Blau |
Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients |
$1,825,920 |
|
Research Training II: |
Theo Palmer |
CIRM Training Program |
$7,475,333 |
|
New Faculty Physician Scientist: |
Michelle Monje |
White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” |
$2,800,536 |
|
Tools and Technologies II: |
Marius Wernig |
Cellular tools to study brain diseases affecting synaptic transmission |
$1,664,382 |
|
Transplantation Immunology: |
Kenneth Weinberg |
“Engineered immune tolerance by Stem Cell-derived thymic regeneration” |
$1,271,783 |
|
Comprehensive Grant: |
Christopher Zarins |
Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells |
$2,454,490 |
|
Basic Biology I: |
Susan McConnell |
Identification and characterization of human ES-derived DA neuronal subtypes |
$1,404,853 |
|
Tools and Technologies II: |
Michele Calos |
Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation |
$1,592,897 |
|
New Faculty II: |
Ching-Pin Chang |
VEGF signaling in adventitial stem cells in vascular physiology and disease |
$3,008,076 |
|
Disease Team Therapy Planning I: |
Robert Robbins |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$73,030 |
|
Disease Team Research I: |
Alfred Lane |
iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa |
$11,039,208 |
|
Basic Biology V: |
Gary Steinberg |
Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery |
$1,178,370 |
|
SEED Grant: |
Joseph Wu |
In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity |
$623,634 |
|
Comprehensive Grant: |
Renee Reijo Pera |
Human oocyte development for genetic, pharmacological and reprogramming applications |
$2,298,411 |
|
Basic Biology IV: |
Howard Chang |
Long noncoding RNAs for pluripotency and cell fate commitment |
$1,386,627 |
|
Basic Biology I: |
Julien Sage |
The retinoblastoma (RB) gene family in cellular reprogramming |
$1,363,171 |
|
Tools and Technologies II: |
Theo Palmer |
Development of small molecule screens for autism using patient-derived iPS cells |
$1,797,981 |
|
SEED Grant: |
Krishna Shenoy |
Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium |
$572,891 |
|
Comprehensive Grant: |
Irving Weissman |
Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells |
$2,471,386 |
|
Training Grant I-1: |
Michael Longaker |
Stanford CIRM Training Program |
$3,035,282 |
|
Major Facilities: |
John Hennessy |
Stanford SIM1 Building |
$43,578,000 |
|
SEED Grant: |
Joanna Wysocka |
Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency |
$629,952 |
|
Early Translational I: |
Michael Longaker |
Enhancing healing via Wnt-protein mediated activation of endogenous stem cells |
$6,464,126 |
|
Basic Biology IV: |
Ben Barres |
Phenotyping Human Astrocytes in Health and Disease |
$0 |
|
Basic Biology I: |
Helen Blau |
Molecular Mechanisms of Reprogramming towards Pluripotency |
$1,408,332 |
|
Disease Team Therapy Development III: |
Irving Weissman |
Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors |
$7,672,364 |
|
SEED Grant: |
Calvin Kuo |
Differentiation of Human Embryonic Stem Cells to Intestinal Fates |
$554,176 |
|
New Faculty I: |
Anne Brunet |
Molecular mechanisms involved in adult neural stem cell maintenance |
$2,348,435 |
|
Disease Team Research I: |
Irving Weissman |
Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells |
$18,759,276 |
|
Disease Team Planning: |
Thomas Rando |
Stem Cell Therapy for Muscular Dystrophy |
$0 |
|
SEED Grant: |
Phillip Yang |
In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction |
$629,952 |
|
Shared Labs: |
Vittorio Sebastiano |
Center for Human Embryonic Stem Cell Research and Education |
$3,434,600 |
|
Basic Biology II: |
Steven Artandi |
Self-renewal and senescence in iPS cells derived from patients with a stem cell disease |
$931,285 |
|
Research Leadership 12: |
Hiromitsu Nakauchi |
Generation of functional cells and organs from iPSCs |
$5,436,308 |
|
SEED Grant: |
John Cooke |
EC regeneration in cerebrovascular ischemia: role of NO |
$476,995 |
|
Comprehensive Grant: |
Roel Nusse |
Guiding the developmental program of human embryonic stem cells by isolated Wnt factors |
$1,710,817 |
|
New Faculty I: |
Howard Chang |
Noncoding RNAs in Cell Fate Determination |
$2,985,894 |
|
New Faculty Physician Scientist: |
Alan Cheng |
Enhancing hair cell regeneration in mouse and human inner ear |
$3,091,595 |
|
New Cell Lines: |
Julie Baker |
Derivation of hESC Lines with Disease Lesions |
$1,404,725 |
|
Disease Team Planning: |
Robert Robbins |
{REDACTED} Cardiovascular Regenerative Team |
$25,119 |
|
Tools and Technologies I: |
Helen Blau |
Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells |
$949,608 |
|
Basic Biology IV: |
Roel Nusse |
Asymmetric stem cell division oriented by a local self-renewing signal |
$1,039,058 |
|
Basic Biology II: |
Garry Nolan |
Kinase signaling analysis of iPS cell reprogramming and differentiation |
$1,343,789 |
|
Basic Biology V: |
Xinnan Wang |
Misregulated Mitophagy in Parkinsonian Neurodegeneration |
$1,174,943 |
|
SEED Grant: |
Aaron Hsueh |
Patient-specific cells with nuclear transfer |
$629,653 |
|
Comprehensive Grant: |
Julie Baker |
Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cell |
$2,518,303 |
|
New Faculty I: |
Karl Deisseroth |
Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny |
$2,424,209 |
|
New Cell Lines: |
Michele Calos |
Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses |
$1,406,875 |
|
Disease Team Therapy Planning I: |
Judith Shizuru |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$90,147 |
|
Shared Labs: |
Renee Reijo Pera |
Center for Human Embryonic Stem Cell Research and Education |
$2,439,590 |
|
SEED Grant: |
Mark Kay |
Novel vectors for gene transfer into human ES cells |
$574,737 |
|
Transplantation Immunology: |
Christopher Contag |
Engineering Embryonic Stem Cell Allografts for Operational Tolerance |
$1,411,588 |
|
Basic Biology IV: |
Anne Brunet |
Energy metabolism and aging pathways in human stem cell reprogramming and differentiation |
$1,414,044 |
|
Basic Biology II: |
Aaron Hsueh |
Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation |
$1,309,018 |
|
Basic Biology V: |
Helen Blau |
Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging |
$1,175,357 |
|
SEED Grant: |
Thomas Wandless |
Reprogramming Differentiated Human Cells to a Pluripotent State |
$380,005 |
|
Comprehensive Grant: |
Theo Palmer |
Immunology of neural stem cell fate and function |
$2,396,000 |
|
New Faculty I: |
Joanna Wysocka |
Trithorax and Polycomb methyltransferase complexes in cell fate determination. |
$2,374,020 |
|
New Cell Lines: |
Michael Longaker |
Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts |
$1,406,636 |
|
Disease Team Therapy Planning I: |
Albert Wong |
Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma |
$109,750 |
|
Genomics Centers of Excellence Awards (R): |
Michael Snyder |
Center of Excellence for Stem Cell Genomics |
$22,831,963 |
|
SEED Grant: |
Julien Sage |
Functions of RB family proteins in human embryonic stem cells |
$498,609 |
|
Transplantation Immunology: |
Robert Negrin |
Regulatory T cell induced tolerance to ESC transplantation |
$1,383,147 |
|
Early Translational II: |
Michele Calos |
Stem Cell Therapy for Duchenne Muscular Dystrophy |
$2,267,900 |
|
Basic Biology III: |
Michael Clarke |
USP16 controls stem cell number: implications for Down Syndrome |
$1,264,032 |
|
Basic Biology V: |
Marius Wernig |
Mechanisms of human induced neuronal cell reprogramming |
$1,178,370 |
|
SEED Grant: |
Kenneth Weinberg |
Embryonic stem cell-derived thymic epithelial cells |
$628,793 |
